Results 91 to 100 of about 54,576 (283)

A protein elicitor PeVn1 from Verticillium nonalfalfae HW recognized as a MAMP triggers plant immunity response

open access: yesFrontiers in Plant Science
Protein elicitors can induce plant systemic resistance to pathogens. The recognition of a potential elicitor activates intracellular signaling events, leading to plant resistance against pathogens.
Ziyu Zhang   +6 more
doaj   +1 more source

Swollen leaf vein (SV) symptom severity scoring system for Nicotiana benthamiana.

open access: yes, 2023
Swollen leaf vein (SV) symptom severity scoring system for Nicotiana benthamiana.
Alison Brigden (15852602)   +2 more
core   +1 more source

Optimization of Biopharming Systems in Nicotiana benthamiana

open access: yes, 2022
In this project, protocols and resources were developed and optimised for the use of the model plant Nicotiana benthamiana as a production host for antibodies and other pharmaceutically important proteins.
openaire   +2 more sources

Structural and thermodynamic analyses of a novel β‐1,2‐glucan binding mode in the ABC transporter solute‐binding protein Chy400_4166 from Chloroflexus aurantiacus

open access: yesThe FEBS Journal, EarlyView.
Cyclic β‐1,2‐glucan (CβG)‐associated solute‐binding protein of type I ABC transporter was originally identified in Chloroflexus aurantiacus, a phototrophic bacterium. Crystal structures in complex with CβGs revealed unique binding modes that are fundamentally distinct from that of the short β‐1,2‐glucooligosaccharides‐binding protein.
Kazuya Kato   +6 more
wiley   +1 more source

Evaluation of Potato virus X mild mutants for cross protection against severe infection in China

open access: yesVirology Journal, 2019
Background Cross protection is a promising alternative to control plant viral diseases. One critical factor limiting the application of cross protection is the availability of attenuated mutants or mild strains.
Q. Q. Cong   +7 more
doaj   +1 more source

SlMED25‐SlPHR3‐SlSPX2 module fine‐tunes SlPHR3‐mediated transcriptional activation of phosphate starvation response in tomato

open access: yesJournal of Integrative Plant Biology, EarlyView.
The Mediator subunit SlMED25 and the co‐repressor SlSPX2 competitively bind the N‐terminal domain of the phosphate starvation response transcription factor SlPHR3 in tomato to form a sensitive molecular switch, which dynamically modulates phosphate starvation responses and maintains phosphate homeostasis, offering valuable targets for breeding low ...
Mingtong Zhai   +10 more
wiley   +1 more source

Characterization of cDNAs from Nicotiana benthamiana that encode proteins which interact with tomato golden mosaic virus AL2 protein in the yeast two-hybrid system

open access: yes, 2003
The AL2 protein of tomato golden mosaic virus (TGMV) is multifunctional. It is required for derepression of the TGMV AR1 gene in phloem tissue, and for trans-activating the AR1 and BR1 genes in mesophyll cells.
Yu, Ming
core  

The ZmRACK1–ZmCDPK7–ZmAPX1 module regulates plant antiviral immunity

open access: yesJournal of Integrative Plant Biology, EarlyView.
In maize, ZmRACK1 acts as a scaffold protein that bridges the cyclin‐dependent kinase ZmCDPK7 and the ascorbate peroxidase ZmAPX1, promoting ZmAPX1 activity to mitigate MCMV infection. Upon viral infection, P31 obstructs formation of the ZmRACK1‐ZmCDPK7‐ZmAPX1 complex, inhibiting ZmCDPK7‐mediated ZmAPX1 activity and promoting reactive oxygen species ...
Yuyang Zhang   +13 more
wiley   +1 more source

Real-time PCR Analysis of PAMP-induced Marker Gene Expression in Nicotiana benthamiana

open access: yesBio-Protocol, 2018
Perception of pathogen-associated molecular patterns (PAMPs) often triggers various innate immune responses in plants. The transcriptional changes of defense-related genes are often used as a marker to assay PAMP-triggered plant immune response.
Fan Liu   +3 more
doaj   +1 more source

Characterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobacco [PDF]

open access: yes, 2014
The proposed clinical trial in Africa of VRC01, a potent broadly neutralizing antibody (bNAb) capable of neutralizing 91% of known HIV-1 isolates, raises concerns about testing a treatment which will be too expensive to be accessible by the most ...
Katja Klein   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy